Soft-tissue sarcoma of the extremity. Experience with limb-sparing surgery

Area of Science:

• Orthopedic Oncology
• Surgical Oncology
• Soft Tissue Sarcoma Research

Background:

• Limb-sparing surgery aims to preserve limb function in sarcoma patients.
• Wide or marginal resection combined with radiotherapy are key limb-sparing interventions.
• Amputation is reserved for cases where limb conservation is not feasible.

Purpose of the Study:

• To evaluate the implementation and outcomes of limb-sparing surgery for soft-tissue sarcomas.
• To compare limb-sparing approaches with traditional amputation rates.
• To identify factors affecting treatment delays and outcomes.

Main Methods:

• Retrospective review of 40 tertiary referral patients undergoing limb-sparing surgery.
• Analysis of 215 sarcoma patients treated in South Australia (1986-1992).
• Assessment of limb conservation success, adjuvant therapies, and median survival time.

Main Results:

• Limb-sparing treatment achieved success in 37 of 40 patients.
• Median survival time was 35 months; 32 patients received radiotherapy, 19 received chemotherapy.
• A higher amputation rate and lower use of combined treatments were observed in the general patient series compared to the limb-sparing group.
• Incorrect initial diagnosis affected 65% of patients, causing a median treatment delay of 16 weeks.

Conclusions:

• Limb-sparing surgery is a viable and effective option for limb sarcomas.
• Wider adoption of limb-sparing techniques is recommended.
• Delayed diagnosis is a critical issue hindering optimal sarcoma treatment and patient outcomes.